And the only p3 outside their core?.....seriously? That's becaus they are focusing on their CORE as they have already updated the market. The fact it's outside their core is not heartening and so ply represents the fact they already committed to undertake it to interim analysis prior to making decisions on their core.
If if anything it just shows Teva is serious about what's core and not. MSB is only outside it becaus they already committed prior. That's no guarantee they have enthusiasm for it going forward. The results will need to be quite compelling. As I already said.
Bickering, page-13
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
-0.055(4.89%) |
Mkt cap ! $1.221B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.06 | $8.816M | 8.055M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 280000 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |